After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. The current market capitalization of Augmedix Inc is $110.28M. A total of 0.83 million shares were traded on the day, compared to an average of 1.30M shares.
In the most recent transaction, Krakaris Emmanuel sold 3,528 shares of AUGX for 1.19 per share on May 15 ’24. After the transaction, the PRESIDENT, CEO, AND SECRETARY now owns 58,898 company shares. In a previous transaction on May 15 ’24, Breber Sandra sold 2,354 shares at 1.19 per share. AUGX shares that CHIEF OPERATING OFFICER owns now total 16,396.
Among the insiders who sold shares, Ginocchio Paul disposed of 2,354 shares on May 15 ’24 at a per-share price of $1.19. This resulted in the CHIEF FINANCIAL OFFICER holding 131,896 shares of AUGX after the transaction. In another insider transaction, Chatterjee Saurav sold 1,767 shares at $1.19 per share on May 15 ’24. Company shares held by the CHIEF TECHNOLOGY OFFICER now total 2,921.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, AUGX has a high of $6.25 and a low of $0.73.
As of this writing, AUGX has an earnings estimate of -$0.13 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.15.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AUGX’s latest balance sheet shows that the firm has $41.26M in Cash & Short Term Investments as of fiscal 2021. There were $14.84M in debt and $13.99M in liabilities at the time. Its Book Value Per Share was $0.36, while its Total Shareholder’s Equity was $24.07M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUGX is Buy with a score of 3.33.
